1 材料与方法
1.1 黄芪主要活性成分筛选及潜在靶点预测
1.2 家兔氧化应激靶点收集
1.3 蛋白质-蛋白质相互作用(protein-protein interaction,PPI)网络构建及关键靶点筛选
1.4 构建黄芪-氧化应激-靶点网络
1.5 基因本体(GO)功能和京都基因与基因组百科全书(KEGG)通路富集分析
1.6 分子对接验证
2 结果
2.1 黄芪活性成分及潜在靶点筛选结果
表1 黄芪中20个活性成分信息Table 1 Information of twenty active ingredients in milkvetch root |
| 编号 No. | TCMSP数据库编号 TCMSP database No. | 化合物名称 Chemical compound name |
|---|---|---|
| AM1 | MOL000211 | 白桦脂酸Mairin |
| AM2 | MOL000239 | 华良姜素Jaranol |
| AM3 | MOL000296 | 常春藤皂苷元Hederagenin |
| AM4 | MOL000033 | (3S,8S,9S,10R,13R,14S,17R)-10,13-二甲基-17-[(2R,5S)-5-丙-2-基辛烷- 2-基]-2,3,4,7,8,9,11,12,14,15,16,17-十二氢-1H-环戊二烯[a]-3-羟基菲 (3S,8S,9S,10R,13R,14S,17R)-10,13-dimethyl-17-[(2R,5S)-5-propan-2- yloctan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1H- cyclopenta[a]phenanthren-3-ol |
| AM5 | MOL000354 | 异鼠李素Isorhamnetin |
| AM6 | MOL000371 | 3,9-二-O-甲基尼森香豌豆紫檀酚3,9-di-O-methylnissolin |
| AM7 | MOL000374 | 5'-羟基异微凸剑叶莎醇-2',5'-二-O-葡萄糖苷 5'-hydroxyiso-muronulatol-2',5'-di-O-glucoside |
| AM8 | MOL000378 | 7-O-甲基异微凸剑叶莎醇7-O-methylisomucronulatol |
| AM9 | MOL000379 | 9,10-二甲氧基紫檀-3-O-β-D-葡萄糖苷 9,10-dimethoxypterocarpan-3-O-β-D-glucoside |
| AM10 | MOL000380 | (6aR,11aR)-9,10-二甲氧基-6a,11a-二氢-6H-苯并吡喃 [3,2-c]-3-醇(6aR,11aR)-9,10-dimethoxy-6a, 11a-dihydro-6H-benzofurano[3,2-c]chromen-3-ol |
| AM11 | MOL000387 | 联苯双酯Bifendate |
| AM12 | MOL000392 | 刺芒柄花Formononetin |
| AM13 | MOL000398 | 二氢异黄酮Isoflavanone |
| AM14 | MOL000417 | 毛蕊异黄酮Calycosin |
| AM15 | MOL000422 | 山奈酚Kaempferol |
| AM16 | MOL000433 | 叶酸Folic acid |
| AM17 | MOL000438 | 黄芪紫檀烷Astraisoflavan-7-O-β-D-glucoside |
| AM18 | MOL000439 | 异微凸剑叶莎醇-7,2'-二-O-葡糖苷 Isomucronulatol-7,2'-di-O-glucosiole |
| AM19 | MOL000442 | 1,7-二羟基-3,9-二甲氧基紫檀烯 1,7-dihydroxy-3,9-dimethoxy pterocarpan |
| AM20 | MOL000098 | 槲皮素Quercetin |
2.2 黄芪抑制家兔氧化应激靶点分析
图1 黄芪活性成分-潜在靶点网络图仅列出靶点中度值排名前10的靶点名称 List only the top 10 target names in degree values ranking。CDK4:细胞周期蛋白依赖激酶4 cyclin-dependent kinase 4;CCND2:细胞周期素D2 cyclin D2;JUN:原癌基因 proto-oncogene;CASP3:半胱氨酸天冬氨酸蛋白酶3 cysteinyl aspartate-specific proteinase 3;EGFR:表皮生长因子受体 epidermal growth factor receptor;CDK2:细胞周期蛋白依赖激酶2 cyclin-dependent kinase 2;SRC:原癌酪氨酸蛋白激酶 proto-oncogene tyrosine-protein kinase;ESR1:雌激素受体1 estrogen receptor 1;INS:胰岛素 insulin;ALB:白蛋白 albumin。图3、图4和图5同 the same as Fig.3, Fig 4 and Fig.5。 圆圈代表对应靶点;长方形对应黄芪活性成分。Circles represent the corresponding targets; rectangles represent the active ingredients of milkvetch root. Fig.1 Network diagram of active ingredient-potential target of milkvetch root |
2.3 PPI网络构建
2.4 黄芪-氧化应激-靶点网络构建
2.5 GO功能注释分析
图6 核心靶点的GO功能分析Biological process:生物过程;peptidyl-serine phosphorylation:肽基丝氨酸磷酸化;negative regulation of apoptotic process:凋亡过程的负调控;transmembrane receptor protein tyrosine kinase signaling pathway:跨膜受体蛋白酪氨酸激酶信号通路;apoptotic process:凋亡过程;regulation of protein localization to plasma membrane:质膜蛋白定位调节;positive regulation of cell proliferation:细胞增殖的正向调节;cellular response to estradiol stimulus:细胞对雌二醇刺激的反应;protein phosphorylation:蛋白质磷酸化;negative regulation of inflammatory response:对炎症反应的负向调节;negative regulation of protein catabolic process:蛋白质分解过程的负向调节:Cellular component:细胞组分;cyclin D2-CDK4 complex:细胞周期蛋白D2-CDK4复合物;spindle microtubule:纺锤体微管;cell-cell junction:细胞-细胞接头;receptor complex:受体复合物;focal adhesion:病灶黏附;transcription factor complex:转录因子复合物;membrane raft:膜筏;lysosome:溶酶体;membrane:膜;mitochondrion:线粒体;Molecular function:分子功能;protein serine/threonine/tyrosine kinase activity:蛋白丝氨酸/苏氨酸/酪氨酸激酶活性;ATP binding:ATP结合;transmembrane receptor protein tyrosine kinase activity:跨膜受体蛋白酪氨酸激酶活性;steroid binding:类固醇结合;RNA polymerase Ⅱ transcription factor activity:RNA聚合酶Ⅱ转录因子活性;phosphotyrosine binding:磷酸酪氨酸结合;identical protein binding:相同蛋白结合;iron ion binding:铁离子结合;non-membrane spanning protein tyrosine kinase activity:非跨膜蛋白酪氨酸激酶活性;steroid binding:类固醇结合。 Fig.6 GO functional analysis of core targets |
2.6 KEGG通路富集分析
图7 核心靶点的KEGG通路富集分析Pathways in cancer:癌症通路;PI3K-Akt signaling pathway:磷脂酰肌醇3激酶-蛋白激酶B信号通路;Viral carcinogenesis:病毒致癌通路;Chemical carcinogenesis-receptor activation:化学致癌-受体激活;Breast cancer:乳腺癌;MAPK signaling pathway:丝裂原激活蛋白激酶信号通路;Estrogen signaling pathway:雌激素信号通路;Human papillomavirus infection:人类乳头瘤病毒感染;Endocrine resistance:内分泌抵抗;Progesterone-mediated oocyte maturation:孕激素介导的卵母细胞成熟。 Fig.7 KEGG pathway enrichment analysis of core targets |
2.7 分子对接验证
表2 核心靶点与相应成分分子对接结果Table 2 Results of molecular docking of core targets and corresponding components |
| 对接靶点 Docking targets | PDB数据库蛋白质 PDB database protein | 编号 No. | 结合能 Binding energy/(kJ/mol) | ||||
|---|---|---|---|---|---|---|---|
白蛋白 ALB | 8BSG | AM1 | -29.6 | ||||
| AM3 | -21.6 | ||||||
| AM4 | -18.4 | ||||||
| AM6 | -22.0 | ||||||
| AM9 | -14.0 | ||||||
| AM10 | -18.4 | ||||||
| AM17 | -16.6 | ||||||
| AM19 | -19.2 | ||||||
表皮生长因子受体 EGFR | 8A27 | AM5 | -21.2 | ||||
| AM7 | -4.5 | ||||||
| AM9 | -16.8 | ||||||
| AM11 | -17.4 | ||||||
| AM15 | -21.3 | ||||||
| AM16 | -14.6 | ||||||
| AM18 | -14.0 | ||||||
| AM20 | -20.2 | ||||||
胰岛素 INS | 4AJX | AM1 | -28.6 | ||||
| AM2 | -23.8 | ||||||
| AM5 | -24.9 | ||||||
| AM6 | -27.1 | ||||||
| AM7 | -11.0 | ||||||
| AM8 | -25.0 | ||||||
| AM9 | -21.3 | ||||||
| AM10 | -25.1 | ||||||
| AM11 | -20.8 | ||||||
| AM13 | -25.8 | ||||||
| AM14 | -29.4 | ||||||
| AM17 | -26.9 |
图8 靶点与化合物分子对接模式图A:ALB-白桦脂酸;B:INS-3,9-二-O-甲基尼森香豌豆紫檀酚;C:INS-毛蕊异黄酮;D:INS-白桦脂酸;E:INS-7-O-甲基异微凸剑叶莎醇;F:INS-黄芪紫檀烷;G:INS-华良姜素;H:INS-(6aR,11aR)-9,10-二甲氧基-6a,11a-二氢-6H-苯并吡喃[2-c]-3-醇;I:INS-二氢异黄酮;J:INS-异鼠李素。 Fig.8 Molecular docking pattern diagram of targets and ingredients A: ALB-mairin; B: INS-3,9-di-O-methylnissolin; C: INS-calycosin; D: INS-mairin; E: INS-7-O-methylisomucronulatol; F: INS-astraisoflavan-7-O-β-d-glucoside; G: INS-jaranol; H: INS-(6aR,11aR)-9,10-dimethoxy-6a,11a-dihydro-6H-benzofurano[2-c]chromen-3-ol; I: INS-isoflavanone; J: INS-isorhamnetin. |
